196 related articles for article (PubMed ID: 22739561)
41. [Treatment with the implantable cardioverter defibrillator (ICD)].
Jordaens LJ
Verh K Acad Geneeskd Belg; 1997; 59(2):107-33. PubMed ID: 9210850
[TBL] [Abstract][Full Text] [Related]
42. Case report: A Chinese child with Andersen-Tawil syndrome due to a de novo KCNJ2 mutation.
Liu XL; Huang XJ; Luan XH; Zhou HY; Wang T; Wang JY; Shen JY; Chen SD; Tang HD; Cao L
J Neurol Sci; 2015 May; 352(1-2):105-6. PubMed ID: 25847018
[No Abstract] [Full Text] [Related]
43. Secondary prevention of sudden cardiac death.
Curnis A; Mascioli G; Bontempi L; Bordonali T; Dei Cas L
Ital Heart J; 2005 Mar; 6(3):216-20. PubMed ID: 15875512
[TBL] [Abstract][Full Text] [Related]
44. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.
Wilkoff BL;
Card Electrophysiol Rev; 2003 Dec; 7(4):468-72. PubMed ID: 15071277
[TBL] [Abstract][Full Text] [Related]
45. Andersen-Tawil syndrome: Clinical presentation and predictors of symptomatic arrhythmias - Possible role of polymorphisms K897T in KCNH2 and H558R in SCN5A gene.
Krych M; Biernacka EK; Ponińska J; Kukla P; Filipecki A; Gajda R; Hasdemir C; Antzelevitch C; Kosiec A; Szperl M; Płoski R; Trusz-Gluza M; Mizia-Stec K; Hoffman P
J Cardiol; 2017 Nov; 70(5):504-510. PubMed ID: 28336205
[TBL] [Abstract][Full Text] [Related]
46. [Andersen-Tawil syndrome. Efficacy of class IC drugs].
Makarov LM; Komoliatova VN; Kolosov VO; Fedina NN; Solokhin IuA
Kardiologiia; 2013; 53(1):91-6. PubMed ID: 23548357
[TBL] [Abstract][Full Text] [Related]
47. Clinical and neurophysiological variability in Andersen-Tawil syndrome.
Kokubun N; Aoki R; Nagashima T; Komagamine T; Kuroda Y; Horie M; Hirata K
Muscle Nerve; 2019 Dec; 60(6):752-757. PubMed ID: 31509255
[TBL] [Abstract][Full Text] [Related]
48. Reversible Dilated Cardiomyopathy Caused by a High Burden of Ventricular Arrhythmias in Andersen-Tawil Syndrome.
Rezazadeh S; Guo J; Duff HJ; Ferrier RA; Gerull B
Can J Cardiol; 2016 Dec; 32(12):1576.e15-1576.e18. PubMed ID: 27789106
[TBL] [Abstract][Full Text] [Related]
49. Identification of the KCNJ2 Mutation in a Korean Family with Andersen-Tawil Syndrome and Developmental Delay.
Kim NR; Jang JH; Jeon GW; Cho EH; Sin JB
Ann Clin Lab Sci; 2016; 46(1):110-3. PubMed ID: 26927354
[TBL] [Abstract][Full Text] [Related]
50. Protein kinase A-dependent biophysical phenotype for V227F-KCNJ2 mutation in catecholaminergic polymorphic ventricular tachycardia.
Vega AL; Tester DJ; Ackerman MJ; Makielski JC
Circ Arrhythm Electrophysiol; 2009 Oct; 2(5):540-7. PubMed ID: 19843922
[TBL] [Abstract][Full Text] [Related]
51. Andersen-Tawil syndrome: clinical and molecular aspects.
Nguyen HL; Pieper GH; Wilders R
Int J Cardiol; 2013 Dec; 170(1):1-16. PubMed ID: 24383070
[TBL] [Abstract][Full Text] [Related]
52. Bidirectional Ventricular Tachycardia in a Young Female: A Case of Andersen-Tawil Syndrome.
Ransom JL; Wong KC; Kircher J; Usry C; Larson C
Mil Med; 2023 Jan; 188(1-2):e412-e416. PubMed ID: 33605413
[TBL] [Abstract][Full Text] [Related]
53. Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy.
Vieira AP; Adragão PP; Santos KR; Morgado FB; Cavaco DM; Rossi R; Abecasis M; Neves JP; Bonhosrst D; Gomes JL; Gomes RS
Rev Port Cardiol; 2005 Mar; 24(3):407-15. PubMed ID: 15929624
[TBL] [Abstract][Full Text] [Related]
54. Swimming-triggered aborted sudden cardiac death in a patient with Andersen-Tawil syndrome.
Efremidis M; Pappas LK; Sideris A; Letsas KP; Gavrielatos GD; Kardaras F
Int J Cardiol; 2006 Sep; 112(2):e45-7. PubMed ID: 16859779
[TBL] [Abstract][Full Text] [Related]
55. Polymorphic ventricular tachycardia and KCNJ2 mutations.
Chun TU; Epstein MR; Dick M; Andelfinger G; Ballester L; Vanoye CG; George AL; Benson DW
Heart Rhythm; 2004 Jul; 1(2):235-41. PubMed ID: 15851159
[TBL] [Abstract][Full Text] [Related]
56. Implantable cardioverter defibrillators in arrhythmogenic right ventricular dysplasia/cardiomyopathy: patient outcomes, incidence of appropriate and inappropriate interventions, and complications.
Schinkel AF
Circ Arrhythm Electrophysiol; 2013 Jun; 6(3):562-8. PubMed ID: 23673907
[TBL] [Abstract][Full Text] [Related]
57. Array comparative genomic hybridization identifies a heterozygous deletion of the entire KCNJ2 gene as a cause of sudden cardiac death.
Marquis-Nicholson R; Prosser DO; Love JM; Zhang L; Hayes I; George AM; Crawford JR; Skinner JR; Love DR
Circ Cardiovasc Genet; 2014 Feb; 7(1):17-22. PubMed ID: 24395924
[TBL] [Abstract][Full Text] [Related]
58. Andersen-Tawil syndrome: management challenges during pregnancy, labor, and delivery.
Subbiah RN; Gula LJ; Skanes AC; Krahn AD
J Cardiovasc Electrophysiol; 2008 Sep; 19(9):987-9. PubMed ID: 18554214
[TBL] [Abstract][Full Text] [Related]
59. [Cardiac arrhythmias in pregnancy].
Trappe HJ; Pfitzner P
Z Kardiol; 2001; 90 Suppl 4():36-44. PubMed ID: 11373942
[TBL] [Abstract][Full Text] [Related]
60. Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the Marburg Cardiomyopathy Study.
Grimm W; Christ M; Bach J; Müller HH; Maisch B
Circulation; 2003 Dec; 108(23):2883-91. PubMed ID: 14623812
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
